What is Mazdutide 10MG?

Mazdutide is a synthetic peptide research compound that functions as a dual agonist of the GLP-1 receptor (GLP-1R) and the glucagon receptor (GCGR). This means it engages two hormone signaling pathways involved in energy balance and metabolism. Mazdutide has been developed and studied as a next-generation incretin-based molecule for metabolic research into obesity, glucose regulation, and lipid metabolism.

In laboratory settings, researchers use mazdutide to explore how simultaneous activation of these two receptors affects metabolic pathways, appetite signaling, energy expenditure, and related cellular processes. It is supplied as a lyophilized peptide powder intended strictly for research use only.

Important: This product is not approved for human or veterinary use and is intended for qualified research laboratories.

Chemical Structure of Mazdutide 10MG

Mazdutide is engineered as a long peptide analog based on glucagon and incretin hormone structures:

Classification: Dual GLP-1R and GCGR agonist peptide

Form: Lyophilized powder for reconstitution in laboratory environments

Purity: Typically ≥98% HPLC-verified research grade.

Unlike small-molecule compounds, mazdutide does not have a single simple chemical formula; it is a peptide with a defined amino acid sequence and structural modifications (including fatty acid acylation) to extend its half-life and improve receptor interaction in metabolic research.

The peptide is generally characterized by advanced analytical methods and supplied with batch-specific quality verification (e.g., HPLC/LC-MS).

What Are the Effects of Mazdutide 10MG?

(Preclinical & Laboratory Research Only)

Mazdutide has been used in metabolic and endocrinological research settings to investigate the integrated effects of dual receptor activation:

Metabolic Regulation & Energy Pathways

Mazdutide activates GLP-1 receptors to support pathways related to nutrient sensing, delayed gastric emptying, and insulin-dependent metabolic signaling. It also activates glucagon receptors to enhance hepatic lipid oxidation and energy expenditure in controlled models. This dual mechanism allows researchers to study coordinated metabolic responses not seen with single-pathway peptides.

Appetite & Satiety Research

In research models, activation of GLP-1 signaling demonstrates suppressed appetite signaling and delayed gastric transit. Combined with glucagon receptor effects, this supports investigations into how distinct pathways contribute to satiety and energy balance.

Glucose Homeostasis Studies

Mazdutide’s dual engagement of receptors involved in glucose metabolism makes it useful in studies examining insulin sensitivity, glucose transport mechanisms, and endocrine regulation of carbohydrate metabolism.

Lipid & Fat Metabolism

By stimulating GCGR alongside GLP-1R, mazdutide research has shown enhanced lipolytic activity and fatty acid oxidation in controlled experimental frameworks. This dual activity helps model how metabolic fuels are balanced under different signaling conditions.

Experimental Therapeutic Modeling

While not used clinically in research settings, mazdutide is explored as a model compound to compare against single-agonist peptides and to understand the biological effects of integrated receptor stimulation on metabolic tissues.